☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Pasithea Therapeutics
Pasithea Therapeutics Acquires AlloMek Therapeutics and Expands CNS-Focused Drug Development Pipeline
October 13, 2022
Pasithea Therapeutics Acquires Alpha-5 Integrin for ~$3.75M to Treat ALS and Other Neurological Diseases
June 23, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.
